These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28763845)

  • 1. [Sivelestat alleviates nonalcoholic steatohepatitis in mice through inhibiting activation of Kupffer cells].
    Zang SF; Ma XJ; Wang L; Zhu GL; Yang WJ; Liu YL; Yan J; Luo Y; Zhuang ZJ; Chen JY; Xun YH; Shi JP
    Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):371-376. PubMed ID: 28763845
    [No Abstract]   [Full Text] [Related]  

  • 2. Neutrophils Play a Crucial Role in the Early Stage of Nonalcoholic Steatohepatitis via Neutrophil Elastase in Mice.
    Zang S; Wang L; Ma X; Zhu G; Zhuang Z; Xun Y; Zhao F; Yang W; Liu J; Luo Y; Liu Y; Ye D; Shi J
    Cell Biochem Biophys; 2015 Nov; 73(2):479-487. PubMed ID: 27352342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cangju Qinggan Jiangzhi Decoction Reduces the Development of NonAlcoholic Steatohepatitis and Activation of Kupffer Cells.
    Cheng Y; Chen T; Ping J; Chen J
    Cell Physiol Biochem; 2018; 48(3):971-982. PubMed ID: 30036865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nicotine alleviates the liver inflammation of non-alcoholic steatohepatitis induced by high-fat and high-fructose in mice].
    Chen XM; Li FQ; Yan S; Wu XC; Tang CL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):777-782. PubMed ID: 27752155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease.
    Leung C; Herath CB; Jia Z; Andrikopoulos S; Brown BE; Davies MJ; Rivera LR; Furness JB; Forbes JM; Angus PW
    World J Gastroenterol; 2016 Sep; 22(35):8026-40. PubMed ID: 27672297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establishment and evaluation of a mouse model of nonalcoholic steatohepatitis-related hepatocellular carcinoma].
    Luo Y; Yang WJ; Chen JY; Zhang J; Zeng XD; Zhuang ZJ; Zang SF; Zhou G; Di CH; Shi JP
    Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):279-84. PubMed ID: 27470627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.
    Okada Y; Yamaguchi K; Nakajima T; Nishikawa T; Jo M; Mitsumoto Y; Kimura H; Nishimura T; Tochiki N; Yasui K; Mitsuyoshi H; Minami M; Kagawa K; Okanoue T; Itoh Y
    Liver Int; 2013 Feb; 33(2):301-11. PubMed ID: 23295058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice.
    Ye D; Li FY; Lam KS; Li H; Jia W; Wang Y; Man K; Lo CM; Li X; Xu A
    Gut; 2012 Jul; 61(7):1058-67. PubMed ID: 22253482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ.
    Tsujimoto S; Kishina M; Koda M; Yamamoto Y; Tanaka K; Harada Y; Yoshida A; Hisatome I
    Int J Mol Med; 2016 Sep; 38(3):721-8. PubMed ID: 27431935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development and evaluation of a high-fat/high-fructose diet-induced nonalcoholic steatohepatitis mouse model].
    Liu J; Liu Y; Wang W; Luo Y; Zhuang Z; Jiao Q; Chen J; Bian D; Ma X; Xun Y; Zhu M; Shi J
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jun; 22(6):445-50. PubMed ID: 25203709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of Sivelestat in a porcine hepatectomy model prepared using an intermittent Pringle method.
    Shimoda M; Iwasaki Y; Okada T; Sawada T; Kubota K
    Eur J Pharmacol; 2008 Jun; 587(1-3):248-52. PubMed ID: 18374331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice.
    Hoo RL; Lee IP; Zhou M; Wong JY; Hui X; Xu A; Lam KS
    J Hepatol; 2013 Feb; 58(2):358-64. PubMed ID: 23108115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK].
    Zhao XY; Zhang LL; Suolang QZ; Yang GY; Li L; Li SB; Chen WW
    Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):849-53. PubMed ID: 25531383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Combination of Geniposide and Chlorogenic Acid Combination Ameliorates Nonalcoholic Steatohepatitis in Mice by Inhibiting Kupffer Cell Activation.
    Xin X; Jin Y; Wang X; Cai B; An Z; Hu YY; Feng Q
    Biomed Res Int; 2021; 2021():6615881. PubMed ID: 34095305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine ameliorates non-alcoholic steatohepatitis in ApoE
    Yang J; Ma XJ; Li L; Wang L; Chen YG; Liu J; Luo Y; Zhuang ZJ; Yang WJ; Zang SF; Shi JP
    Exp Ther Med; 2017 Nov; 14(5):4134-4140. PubMed ID: 29075339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic vagus nerve regulates Kupffer cell activation via α7 nicotinic acetylcholine receptor in nonalcoholic steatohepatitis.
    Nishio T; Taura K; Iwaisako K; Koyama Y; Tanabe K; Yamamoto G; Okuda Y; Ikeno Y; Yoshino K; Kasai Y; Okuno M; Seo S; Sakurai T; Asagiri M; Hatano E; Uemoto S
    J Gastroenterol; 2017 Aug; 52(8):965-976. PubMed ID: 28044208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactobacillus paracasei Induces M2-Dominant Kupffer Cell Polarization in a Mouse Model of Nonalcoholic Steatohepatitis.
    Sohn W; Jun DW; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
    Dig Dis Sci; 2015 Nov; 60(11):3340-50. PubMed ID: 26143342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of sivelestat and N-acetylcysteine alleviates the inflammatory response and exceeds standard treatment for acetaminophen-induced liver injury.
    Raevens S; Van Campenhout S; Debacker PJ; Lefere S; Verhelst X; Geerts A; Van Vlierberghe H; Colle I; Devisscher L
    J Leukoc Biol; 2020 Feb; 107(2):341-355. PubMed ID: 31841237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
    Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
    World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.